New hope for scleroderma patients with scarred lungs
Disease control
Recruiting now
This study aims to test several new investigational drugs to see if they can slow or stop the progression of lung scarring in people with scleroderma. It will enroll 400 adults who have had scleroderma symptoms for 7 years or less and have evidence of lung involvement. Participan…
Phase: PHASE2 • Sponsor: Scleroderma Research Foundation, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC